Women who trialed the newly-launched OdonAssist, an innovative inflatable birth device invented by a car mechanic, praised it as a much-needed alternative to outdated methods like forceps and ventouse, claiming it provided a gentler and less invasive experience during childbirth. #ChildbirthInnovation #PregnancyCare #BirthRevolution #AR #GB #ZA
Maria Patzwald, diagnosed with pre-eclampsia during her second pregnancy, participated in a pioneering trial aimed at treating the condition by targeting a specific protein, which successfully extended her pregnancy by ten days, significantly improving her baby’s chances of survival at birth. #Pregnancy #PreEclampsia #MaternalHealth #US #DE #GB
Maria Patzwald, a 38-year-old expectant mother diagnosed with severe preeclampsia, participated in a pioneering trial that targeted a specific protein believed to be responsible for the condition, resulting in the safe extension of her pregnancy by ten days and a healthier delivery for her son, highlighting the potential of new treatments to address the root causes of preeclampsia and improve maternal and newborn outcomes. #Pregnancy #Health #Research #US #DE #GB
Maria Patzwald, a 38-year-old woman diagnosed with severe preeclampsia during her second pregnancy, participated in a pioneering clinical trial that targeted a specific protein believed to cause the condition, leading to a significant extension of her pregnancy by 10 days and an increased survival chance for her premature son. #Pregnancy #Preeclampsia #MedicalResearch #US #DE #GB
Maria Patzwald, a 38-year-old mother, participated in a pioneering trial aimed at treating preeclampsia—which affects many pregnancies and poses serious risks—by targeting a specific protein in the blood, leading to a successful extension of her pregnancy by two weeks and improving the chances of survival for her premature son. #Pregnancy #HealthInnovation #PreEclampsia #US #DE #GB
Maria Patzwald, a 38-year-old woman, shares her experience of being part of a pioneering clinical trial aimed at treating preeclampsia, a potentially fatal pregnancy complication, which helped extend her pregnancy by ten days, leading to the safe birth of her son at 34 weeks, significantly improving his chances of survival. #PregnancyHealth #PreEclampsia #MaternalCare #US #DE #GB
Maria Patzwald credits a groundbreaking trial that targeted a protein believed to cause preeclampsia for helping her son be born at 34 weeks, potentially improving outcomes for premature infants and offering new hope for treatment options in managing the condition that affects thousands of mothers and babies globally each year. #Pregnancy #Healthcare #Innovation #US #DE #GB
Maria Patzwald, a 38-year-old woman diagnosed with preeclampsia during her second pregnancy, participated in a pioneering trial aimed at treating the condition by targeting a specific protein, which led to her son being born at 34 weeks, significantly increasing his chances of survival. #Pregnancy #Healthcare #PreEclampsia #US #DE #GB
A 38-year-old woman named Maria Patzwald participated in a pioneering trial aimed at treating preeclampsia, a potentially fatal pregnancy complication, and her involvement helped extend her son's gestation by two weeks, significantly improving his chances of survival. #PregnancyCare #MedicalResearch #PreEclampsia #US #DE #GB
Maria Patzwald, a 38-year-old pregnant woman diagnosed with severe preeclampsia, participated in a pioneering trial aimed at treating the condition, which affects maternal and neonatal health, and was able to have her son born at 34 weeks, significantly improving his chances of survival. #PregnancyHealth #PreEclampsia #MaternalHealth #US #DE #GB
A 38-year-old woman named Maria Patzwald participated in a pioneering trial aimed at treating preeclampsia, a serious pregnancy complication, which allowed her to safely extend her pregnancy by 10 days, resulting in her son being born at 34 weeks, significantly improving his chances of survival. #Pregnancy #PreEclampsia #MaternalHealth #US #DE #GB
A 38-year-old woman, Maria Patzwald, participated in a pioneering trial for treating preeclampsia, a serious pregnancy complication, which helped extend her pregnancy by ten days, allowing her son Bennet to be born at 34 weeks, significantly improving his chances of a healthy outcome. #Pregnancy #Preeclampsia #MedicalResearch #US #DE #GB
Maria Patzwald, a 38-year-old mother, credits a pioneering treatment trial for helping manage her severe preeclampsia during pregnancy, which extended her son's gestation by ten days and ultimately allowed him to be born at week 34, significantly increasing his chances of survival. #MaternalHealth #PregnancyResearch #Preeclampsia #US #DE #GB
A mother's experience with NHS rules on miscarriage support highlights the emotional struggle faced by women who must endure multiple losses before receiving help, prompting calls for a more supportive Graded Model of Miscarriage Care that would provide assistance after a first miscarriage. #PregnancyLoss #MiscarriageSupport #MentalHealth #GB #SC #WL #NI
A comprehensive analysis of over 25 million pregnancies indicates that the use of antidepressants during pregnancy does not increase the risk of developmental disorders such as autism or ADHD in children, challenging claims made by U.S. Health Secretary Robert F. Kennedy Jr., and highlighting the need for careful consideration of maternal mental health during pregnancy. #MentalHealth #Pregnancy #AutismResearch #US #HK #UK
A comprehensive analysis of data from over 25 million pregnancies indicates that the use of antidepressants during pregnancy does not increase the risk of developmental disorders like autism or ADHD in children, challenging claims made by U.S. Health Secretary Robert F. Kennedy Jr. about potential risks associated with these medications. #MentalHealth #Pregnancy #AutismResearch #US #HK #UK
A recent analysis of data from over 25 million pregnancies found that the use of antidepressants during pregnancy does not increase the risk of developmental disorders like autism or ADHD in children, contradicting claims made by U.S. Health Secretary Robert F. Kennedy Jr. regarding potential risks associated with these medications. #MentalHealth #Pregnancy #ChildDevelopment #US #HK #UK
A recent analysis of over 25 million pregnancies indicates that the use of antidepressants during pregnancy does not significantly increase the risk of developmental disorders such as autism or ADHD in children, contradicting claims made by U.S. Health Secretary Robert F. Kennedy Jr. #MentalHealth #Pregnancy #AutismResearch #US #HK #UK
A recent analysis of over 25 million pregnancies indicates that the use of antidepressants during pregnancy does not increase the risk of developmental disorders like autism, contradicting unfounded assertions made by U.S. Health Secretary Robert F. Kennedy Jr., while also highlighting the significance of maternal mental health in assessing potential risks to children. #MentalHealth #Pregnancy #AutismResearch #US #HK #UK
A new international study suggests that children may develop a preference for certain vegetables based on flavours they were exposed to in the womb, indicating that maternal diet during pregnancy can influence children's future food preferences. #HealthyEating #FoodPreferences #PregnancyNutrition #GB #FR #NL
